You can buy or sell Athira Pharma and other stocks, options, and ETFs commission-free!
Athira Pharma, Inc. Common Stock, also called Athira Pharma, is a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company was founded by Leen Kawas and Joseph Harding in 2011 and is headquartered in Seattle, WA. The listed name for ATHA is Athira Pharma, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 15, After Hours